メインナビゲーションにスキップ
検索にスキップ
メインコンテンツにスキップ
富山大学 ホーム
日本語
English
ホーム
プロファイル
研究部門
プロジェクト
研究成果
データセット
受賞
活動
コース
専門知識、名前、または所属機関で検索
内科学（第一）講座
富山大学
医学系
概要
フィンガープリント
ネットワーク
プロファイル
(11)
プロジェクト
(12)
研究成果
(394)
フィンガープリント
内科学（第一）講座が活動している研究トピックを掘り下げます。これらのトピックラベルは、この組織のメンバーの研究成果に基づきます。これらがまとまってユニークなフィンガープリントを構成します。
並べ替え順
重み付け
アルファベット順
Keyphrases
Type 2 Diabetes Mellitus (T2DM)
100%
Insulin Resistance
82%
Insulin
63%
Type 2 Diabetic Patients
44%
Insulin Receptor Substrate 1 (IRS1)
44%
Japanese Patients
38%
Japanese Population
35%
Ipragliflozin
34%
IRS2
32%
STELLA
30%
Mitogen-activated Protein Kinase
29%
High-fat Diet
28%
Tyrosine Phosphorylation
26%
Adipose Tissue
26%
Lung Cancer
25%
Phosphoinositide 3-kinase (PI3K)
24%
Obesity
24%
Diabetes
23%
Non-small Cell Lung Cancer (NSCLC)
23%
Post-marketing Surveillance
23%
Old Japanese
23%
Adiponectin
22%
Peroxisome Proliferator-activated Receptor
22%
Gene-deficient Mice
22%
Insulin Receptor
21%
Liver
21%
Macrophages
21%
Subgroup Analysis
20%
Single nucleotide Polymorphism
20%
Older Men
19%
Adipocyte
19%
Body Mass Index
18%
Homozygous Familial Hypercholesterolemia (HoFH)
18%
Insulin Sensitivity
17%
Metabolic Syndrome
17%
Growth Factors
16%
Hemoglobin A1c (HbA1c)
16%
Tumor Necrosis Factor-α
16%
Myocytes
16%
Insulin Signaling
15%
Phosphorylation
15%
Insulin-like
15%
Impaired Glucose Tolerance
15%
Chemotherapy
15%
Japanese Workers
14%
Visceral Adipose Tissue
14%
Asthma
14%
Gut Microbiota
14%
Japan
14%
Sirtuin 1 (SIRT1)
13%
Monotherapy
13%
Glucose Metabolism
12%
3T3-L1 Adipocytes
12%
Type 1 Diabetes Mellitus (T1DM)
12%
Protein Kinase
11%
Fasting Plasma Glucose
11%
Chest Pain
11%
Tyrosine
11%
Older Women
11%
Chest Radiograph
10%
Polymorphism
10%
Rheumatoid Arthritis
10%
Adverse Drug Reaction
10%
High-density Lipoprotein Cholesterol (HDL-C)
10%
Adipose Tissue Macrophages
10%
Alanine Aminotransferase
10%
Progression-free Survival
10%
IgG4-related Disease (IgG4-RD)
10%
Serum Adiponectin
9%
Type 2 Diabetes Mellitus Patients
9%
Hypoxia
9%
Serum Levels
9%
M2 Macrophages
9%
Diabetic Patients
9%
Chest CT
9%
Kinase Activity
9%
Long-term Efficacy
9%
CD206
9%
Elderly Patients
9%
Small Cell Lung Cancer
8%
Insulin Receptor Kinase
8%
Tyrosine Kinase Activity
8%
Diet-induced Obese Mice
8%
Triglycerides
8%
Risk Factors
8%
Epidermal Growth Factor
8%
Chinese Hamster Ovary Cells
8%
Japanese Subjects
8%
Replication Study
8%
Clinical Characteristics
8%
Vascular Endothelial Growth Factor
8%
Lung Adenocarcinoma
8%
Insulin Action
8%
Waist Circumference
8%
Astaxanthin
8%
SIRT1 Activator
8%
Autism Spectrum Disorder
8%
Cholesteryl Ester Transfer Protein Deficiency
8%
Non-elderly
8%
Epidermal Growth Factor Receptor-tyrosine Kinase Inhibitor (EGFR-TKI)
8%
Biochemistry, Genetics and Molecular Biology
Insulin Receptor
64%
Insulin Resistance
62%
Adipocyte
41%
Kinase
29%
Phosphotransferase
29%
Mitogen-Activated Protein Kinase
28%
Single-Nucleotide Polymorphism
26%
Adiponectin
25%
Phosphoinositide 3-Kinase
23%
Tyrosine Phosphorylation
22%
Macrophage
19%
Peroxisome Proliferator-Activated Receptor
18%
Tyrosine
17%
Receptor Tyrosine Kinase
16%
Cardiac Muscle Cell
16%
Insulin Sensitivity
16%
Glucose Blood Level
15%
Impaired Glucose Tolerance
14%
Protein Kinases
14%
Blood Plasma
13%
Tyrosine Kinase
13%
Allele
12%
Triglyceride
12%
Cell Function
12%
Glucose Transport
12%
Insulin Release
11%
Signal Transduction
11%
3T3-L1
11%
T Cell
11%
Glucose Metabolism
10%
Synapsin I
10%
Genetics
10%
Sirtuin1
10%
Insulin-Like Growth Factor 1
9%
Genome-Wide Association Study
9%
Tumor Necrosis Factor
9%
Genotyping
9%
Genetic Divergence
9%
Insulin Signaling
9%
Preadipocyte
8%
HDL-Cholesterol
8%
Body Mass
8%
Mouse Mutant
8%
Mitochondrial Membrane Transport Protein
8%
Carrier Protein
8%
Chinese Hamster
8%
Familial Hypercholesterolemia
8%
Cholesteryl Ester
8%
Vascular Endothelial Growth Factor
7%
Cytokine
7%
Prevalence
7%
Knockout Mouse
7%
Intestine Flora
7%
C-Fos
7%
Genetic Variation
7%
Transgenic Mouse
7%
Epidermal Growth Factor
7%
Epidermal Growth Factor Receptor
7%
Case-Control Study
7%
Messenger RNA
6%
Fibroblast
6%
Osteoclastogenesis
6%
Glucose Tolerance Test
6%
Glucose Test
6%
Gene Expression
6%
Secretion (Process)
6%
Adipose Tissue Macrophages
6%
Pioglitazone
6%
Autoantibodies
6%
Angiotensin
6%
Hypertriglyceridemia
6%
Myeloid
6%
Cancer Cell
6%
Osteoclast
6%
Genetic Background
6%
Reoxygenation
6%
Blood Level
5%
C-Terminus
5%
Dyslipidemia
5%
Wild Type
5%
Downregulation
5%
Wild Type Mouse
5%
IRS1
5%
Autophosphorylation
5%
Genetic Risk
5%
Glucagon
5%
C-Peptide
5%
Waist Circumference
5%
Gene Mutation
5%
Single Nucleotide Polymorphism
5%
RANKL
5%
Growth Hormone
5%
Bovine Somatotropin
5%
Enzyme
5%
Astaxanthin
5%
Cell Growth
5%
Medicine and Dentistry
Maturity Onset Diabetes of the Young
45%
Insulin Resistance
27%
Lung Cancer
24%
Diabetes
23%
Diabetes Mellitus
19%
Chemotherapy
16%
Peroxisome Proliferator Activated Receptor
15%
Adipose Tissue
15%
Disease
14%
Thorax Radiography
14%
High Fat Food
13%
Patient with Type 2 Diabetes
13%
Non Small Cell Lung Cancer
13%
Gut Microbiota
12%
Rheumatoid Arthritis
12%
Inflammatory Arthritis
12%
Lung
12%
Metabolic Syndrome
11%
Adipocyte
11%
Small Cell Lung Cancer
10%
Sirtuin1
10%
Asthma
9%
Insulin Dependent Diabetes Mellitus
9%
Thorax Pain
9%
Immune Checkpoint Inhibitor
9%
Immunoglobulin G4
9%
Diet Induced Obesity
9%
Pulmonary Hypertension
8%
Monotherapy
8%
Lung Adenocarcinoma
8%
Disease Course
8%
Hemoglobin A1c
8%
Ipragliflozin
8%
Subgroup Analysis
8%
Familial Hypercholesterolemia
8%
Body Mass Index
8%
Glucose Metabolism
7%
Triacylglycerol
7%
Systemic Lupus Erythematosus
7%
Macrophage
7%
Retrospective Study
7%
Cell Function
6%
Transgenic Mouse
6%
Prednisolone
6%
IgG4-Related Disease
6%
Neoplasm
6%
Metastatic Carcinoma
6%
Coughing
6%
Adiponectin
6%
Insulin Receptor
6%
Body Weight
5%
Pleura Effusion
5%
Biopsy Technique
5%
Tumor Necrosis Factor
5%
C-Peptide
5%
Gut Microbiome
5%
Rituximab
5%
Computer Assisted Tomography
5%
Insulin Signaling
5%
T Cell
5%
Receptor
5%
Recurrent Disease
5%
Dyspnea
5%
Middle Age
5%
Single Nucleotide Polymorphism
5%
Phosphoinositide 3-Kinase
5%
Observational Study
5%